Literature DB >> 631503

A model of fulminant hepatic failure in the rabbit.

B L Blitzer, J G Waggoner, E A Jones, H R Gralnick, D Towne, J Butler, V Weise, I J Kopin, I Walters, P F Teychenne, D G Goodman, P D Berk.   

Abstract

A highly reproducible model of fulminant hepatic failure was developed by administering intravenously the selective hepatotoxin galactosamine hydrochloride (4.25 mmoles per kg) to genetically uniform rabbits. The great majority of rabbits died between 21 and 44 hr after injection following a period of coma which lasted 2.6 hr on average. Serum biochemical tests and liver histology reflected massive hepatic injury. Changes in plasma ammonia and amino acid concentrations, in coagulation parameters, and in the electroencephalogram were similar to those found in human fulminant hepatic failure. This model appears promising for future studies of the pathogenesis and treatment of fulminant hepatic failure.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 631503

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  25 in total

Review 1.  Animal models of acute hepatic failure.

Authors:  T M Rahman; H J Hodgson
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

2.  A Macaca mulatta model of fulminant hepatic failure.

Authors:  Ping Zhou; Jie Xia; Gang Guo; Zi-Xing Huang; Qiang Lu; Li Li; Hong-Xia Li; Yu-Jun Shi; Hong Bu
Journal:  World J Gastroenterol       Date:  2012-02-07       Impact factor: 5.742

Review 3.  Animal models of fulminant hepatic failure.

Authors:  J Terblanche; R Hickman
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

4.  Effect of extracorporeal bioartificial liver support system on fulminant hepatic failure rabbits.

Authors:  Ying-Jie Wang; Meng-Dong Li; Yu-Ming Wang; Guo-Zheng Chen; Guo-Dong Lu; Zao-Xia Tan
Journal:  World J Gastroenterol       Date:  2000-04       Impact factor: 5.742

5.  Hepatoprotective effect of nitric oxide in experimental model of acute hepatic failure.

Authors:  Marek Saracyn; Marek Brytan; Robert Zdanowski; Tomasz Ząbkowski; Przemysław Dyrla; Janusz Patera; Stanisław Wojtuń; Wojciech Kozłowski; Zofia Wańkowicz
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

6.  A dog model for acetaminophen-induced fulminant hepatic failure.

Authors:  A Francavilla; L Makowka; L Polimeno; M Barone; J Demetris; J Prelich; D H Van Thiel; T E Starzl
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

7.  Extra- and intracellular amino acids in the hippocampus during development of hepatic encephalopathy.

Authors:  A Hamberger; B Nyström
Journal:  Neurochem Res       Date:  1984-09       Impact factor: 3.996

8.  Evidence for the presence of a benzodiazepine receptor binding substance in cerebrospinal fluid of a rabbit model of hepatic encephalopathy.

Authors:  K D Mullen; J V Martin; W B Mendelson; K Kaminsky-Russ; E A Jones
Journal:  Metab Brain Dis       Date:  1989-12       Impact factor: 3.584

9.  Effects of daily, light and moderate-heavy ethanol exposure on extent of hepatic injury and recovery following toxin-induced acute hepatitis in rats.

Authors:  Manna Zhang; Julia Uhanova; Ian Corbin; Charles Bernstein; Gerald Y Minuk
Journal:  Dig Dis Sci       Date:  2003-05       Impact factor: 3.199

Review 10.  An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure.

Authors:  María-Jesús Tuñón; Marcelino Alvarez; Jesús-M Culebras; Javier González-Gallego
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.